Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page
- Check5 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and added information regarding the HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated to reflect a new certification/extension date of July 11, 2025, and the revision has been changed from v2.16.5 to v2.16.6.SummaryDifference0.3%
- Check19 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.9%
- Check27 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.5) and indicates that the product is now approved for public sale. Previous information regarding the modernization of ClinicalTrials.gov data ingest has been removed.SummaryDifference1%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check55 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.